Revival of tetracyclines--in the treatment of visceral leishmaniasis?
A 37-year-old immigrant from Kosovo who had been in Switzerland for 2 years developed fever, cough, weight loss and malaise. Serology (complement binding reaction) was positive for leptospirosis. The symptoms resolved very rapidly under vibramycin 2 x 100 mg/day for 3 weeks. However, a flare-up occurred after cessation of medication. Reexposure to tetracyclines improved the symptoms though they did not subside completely. Bone marrow analysis demonstrated intracellular leishmania (amastigotes). Analysis of frozen serum preserved since the first hospitalisation and samples from the second admission were positive for leishmania (indirect fluorescence antibody test) and confirmed the diagnosis of visceral leishmaniasis. Reevaluation of the serology for leptospirosis was negative using the specific microagglutination method. Treatment with antimony for 28 days resolved all symptoms. The parasites of visceral leishmaniasis grow intracellularly and eradication may be impossible in patients with an impaired cellular immune response. Flare-ups thus recur in 60-100% of patients with organ transplants or AIDS, despite regular treatment. Our finding raises the question whether relapses are suppressed in immunocompromised patients by tetracyclines, drugs known to be well tolerated even under long-term exposure. Randomised studies are required in this setting.
Department of Internal Medicine, Kantonsspital Lucerne.
K
K
Heer
D
D
Pfister
V
V
Briner
D000328:Adult; D000965:Antimony / Q000627:therapeutic use; D004318:Doxycycline / Q000009:adverse effects / Q000627:therapeutic use; D006801:Humans; D007898:Leishmaniasis, Visceral / Q000175:diagnosis / Q000188:drug therapy*; D008297:Male; D009894:Opportunistic Infections / Q000175:diagnosis / Q000188:drug therapy; D012008:Recurrence; D013754:Tetracyclines / Q000009:adverse effects / Q000627:therapeutic use*; D016896:Treatment Outcome
D013754:Tetracyclines; D000965:Antimony; D004318:Doxycycline